Amount Raised
$50 Million
Round Type
Series B
SouthlakeBiotechnologyHealth CareMedicalTherapeuticsDescription
OncoNano Medicine, Inc. today announced the raise of an approximate $50 million Series B financing led by the healthcare investment team at Advantech Capital, a China-based cross border institutional investment fund. Proceeds of the financing will be used, in part, to support the Phase 3 clinical trials in the U.S. and Europe for pegsitacianine, an innovative real-time imaging agent used in intraoperative surgical resection of solid tumors, and accelerate the advancement of the company’s first therapeutic development program, ONM-501, a novel immune-therapeutic formulated with the company’s core delivery technology.
Quick answer
OncoNano Medicine raised $50 Million in a Series B round, dated June 17, 2021. OncoNano Medicine is based in Southlake, Texas, United States.
- How much did OncoNano Medicine raise?
- OncoNano Medicine raised $50 Million in a Series B round on June 17, 2021.
- What does OncoNano Medicine do?
- OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics.
- Where is OncoNano Medicine based and how big is it?
- OncoNano Medicine is based in Southlake, Texas, United States. Fundz records about 23 employees.
- Who are the decision-makers at OncoNano Medicine?
- Fundz holds 1 contact at OncoNano Medicine, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as OncoNano Medicine that raised within 45 days of this round, from Fundz verified event records.
- Pulse Biosciences, Inc. raised $50M on July 9, 2021.
- Immunome Inc. raised an undisclosed amount (Grant) on May 20, 2021.
- MAIA Biotechnology raised $8M (Funding Round) on May 19, 2021.
- Immunome Inc. raised $27M on May 11, 2021.
- Edwards Lifesciences raised $100K (Pre-Seed) on July 27, 2021.
- Sanara MedTech raised $500K (Seed) on July 27, 2021.
Who to call at OncoNano Medicine, and when
A new round usually means OncoNano Medicine is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OncoNano Medicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OncoNano Medicine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OncoNano Medicine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OncoNano Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansOncoNano Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.